Antenatal complications Flashcards
Uncomplicated nausea and vomiting in prengancy
affects 80% of women
Typically week 8-14
10% of pregnancies will have continued n+v beyond 20w until birth
Definition of hyperemesis gravidarum
Severe, intractable vomiting in pregnancy that results in inability to maintain hydration orally, metabolic disturbance, and admission to hospital for parenteral hydration
Prevalence of hyperemesis gravidarum
Occurs in less than 1% of pregnancies
Pathogenesis of hyperemesis gravidarum
Hormonal (hCG and oestrogen)
Mechanical (red LOS tone, gastric peristalsis and gastric emptying)
?Emotional
Complications of hyperemesis gravidarum
Hyponatremia Hypokalemia Metabolic hypochloraemic alkalosis Ketonuria Raised haematocrit Increased specific gravity of urine Wernicke's encephalopathy
Investigations if suspecting hyperemesis gravidarum
Urinalysis and MCS Stool culture EUC BGL (if diabetic) LFTs TFTs (?thyrotoxicosis) Serum amylase (?pancreatitis) Ultrasound (?ongoing pregnancy, multiple, molar) Abdominal erect and supine x-rays (?bowel obs)
Management of hyperemesis gravidarum
IV hydration if required (0.9% Na + K or Hartmann’s)
Glucose and vitamins (esp. thiamine) if prolonged vomiting
- administer thiamine first to prevent Wernickes
Dietary modification (small frequent low-fat meals, early when hungry)
Alternative (acupuncture, Ginger, multivitamins[B6])
Pharmacologic
Antiemetics for use in Hyperemesis gravidarum
Metoclopramide 10mg TDS
Doxylamine 25mg nocte
Promethazine 25mg BD (sedation)
Prochlorperazine 25mg suppository 1-2/day
Ondansetron 4-8mg oral or IV (if IV rehydration, thiamine and electrolyte correction)
Corticosteroids if refractory
Complication of use of corticosteroids in first trimester of pregnancy
Increased risk of oral clefting
Definition of oligohydramnios
An amniotic fluid volume that is less than expected for gestational age
Causes of oligohydramnios
Placental (3) - abruption - twin-twin transfusion - placental thrombosis/ischaemia Foetal (6) - Chromosomal abnormalities - congenital abnormalities (esp if impairs urine production e.g. renal obstruction) - Growth restriction (blood flow redirected away from kidneys) - intrauterine foetal demise - post-term pregnancy - ruptured foetal membranes Maternal (7) - Medical: - chronic HTN - collagen vascular disease - nephropathy - thrombophilia - Obstetric: - Preeclampsia - medications: - ACE-inhibitors - NSAIDs
Normal daily foetal urine production
800-1200mL/day
Normal volume swallowed by foetus per day
500-1000mL/day
Normal measurements of amniotic fluid
Deepest volume pocket (DVP) 2-8cm
Amniotic fluid index (sum of 4 quadrant DVP) 5-25
Measurement of oligohydramnios in multiple pregnancy
Single deepest pocket (SDP) under 2cm
Components of biophysical profile (5)
Foetal HR Foetal breathing movements Foetal activity/gross body movement Foetal muscle tone Qualitative AFI
Management of oligohydramnios
Identify cause (history, USS)
+/- Increase amniotic fluid
Serial USS to monitor AFI and foetal growth (weekly, 4-weekly respectively)
+Non-stress testing +/- Biophysical profile
Likely to require early delivery
Indications to increase amniotic fluid volume in oligohydramnios
Improve detection of foetal anomalies
Facilitate cephalic version
Prevent foetal sequelae
Methods to increase amniotic fluid volume in oligohydramnios
Amnioinfusion
Maternal hydration
Foetal membrane sealants (if leaking PPROM)
Commonest causes for severe polyhydramnios
Foetal anomalies (particularly trisomy 21)
Maternal and idiopathic factors are more often associated with milder cases
Incidence of polyhydramnios
1-2% of pregnancies
What syndrome is suggested by IUGR plus polyhydramnios
Trisomy 18
Causes of polyhydramnios
Foetal (33%) - Chromosomal anomalies - CNS: ancephaly, hydrocephalus - GI: oesophageal atresia/TOF, facial clefts (impaired swallowing) - Neuromuscular condition inhibiting swallowing Maternal: - Type 1 DM (disordered transchorionic flow) Maternal-foetal - Chorioangioimas - Multiple gestation - Foetal hydrops Idiopathic (40%)
Causes of foetal hydrops
Anaemia (thalassaemia, virus, ABO incompatibility)
Congestive heart failure
Infection (TORCH, syphilis, varicella)
Obstructed lymphatic flow
Red. plasma oncotic pressure (liver disease, nephropathy)
Metabolic storage disease
Thoracic abnormalities (e.g. chylothorax, diaphragmatic hernia)
AV and venous malformations
GI malformations
GU malformations
Twin gestation (twin-twin transfusion syndrome)
Clinical features of polyhydramnios
Uterine size large for dates
FLUID THRILL
Mother may experience SOB, uterine irritability and contractions, abdominal discomfort
Ultrasonographic findings of polyhydramnios
Single deepest pocket greater than 8cm
AFI greater than 24 cm
Management options of polyhydramnios
Antepartum foetal monitoring Nonstress test + biophysical profile every 1-2 weeks until 37 weeks (more often if severe) Amnioreduction if severe and symptomatic Indomethacin Generally induce labour early
Indomethacin use in polyhydramnios (dose, side effects, contraindications)
25mg orally QID (works in 2-3d)
S/E: nausea, reflux, gastritis, vomiting, platelet dysfunction
Foetal A/E: constriction of ductus arteriosus, necrotising enterocolitis, intraventricular haemorrhage
Contraindicated after 32 weeks (risk of closure of ductus)
Mechanism of action of indomethacin in polyhydramnios
Stimulates foetal ADH secretion - antidiuretic response in kidneys + reduced renal blood flow - reduced foetal urine production
Prognosis of polyhydramnios
Increased risk of perinatal mortality (2- to 5- fold)
Many IDIOPATHIC cases resolve spontaneously
Complications related to polyhydramnios
Maternal respiratory compromise Preterm labour, PPROM, preterm delivery Foetal malposition Macrosomia Umbilical cord prolapse Placental abruption upon rupture of membranes Postpartum uterine atony - PPH
Definition of IUGR
A foetal weight below the 10th percentile for gestational age
- typically if following normal growth trajectory, normal Doppler of umbilical artery and normal amniotic fluid volume, likely to be constitutional SGA
Categories of IUGR
Symmetric: body and head growth reduced
- begins in EARLY gestation
- usually INTRINSIC factors (chromosomal, congenital)
Asymmetric (head-sparing): usually just reduced weight(AC) with normal length and head
- begins in late SECOND or THIRD trimesters
- Due to reductions in foetal nutrients - limited fat storage but enough to allow continued brain growth
Maternal causes of IUGR (9)
Severe starvation
Hypoxaemia
Haematologic/immunologic causing thrombosis
Medical or obstetric conditions associated with vasculopathy (PET, nephropathy, vascular disease)
TORCH, malaria
Substance abuse
Toxin exposure (warfarin, AEDs, folic acid antagonists)
High altitude
Demographic (rage, age, size, previous SGA)